Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro typically begins affecting appetite within the first one to two weeks of treatment, though most people notice meaningful weight change after four to eight weeks. The medicine activates two gut-hormone receptors simultaneously, slowing gastric emptying and increasing satiety signals to the brain. It is a prescription-only medicine requiring clinical assessment before it can be dispensed. That early biological activity is real — but what it looks like day-to-day is often misunderstood, and the biggest misconception is worth addressing before anything else.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is probably the most common expectation our prescribers hear. Someone starts their first Mounjaro pen, checks the scales after five days, and feels disheartened when the number has barely moved. The assumption (that a medicine working on appetite should produce visible weight loss almost immediately) is understandable but gets the biology slightly wrong.
What happens first is a shift in hunger signals, not fat loss. Mounjaro activates both GIP and GLP-1 receptors, which together slow how quickly food leaves your stomach and reduce the appetite signals your brain receives. That process begins with the first dose. But the calories-in side of the equation only starts to fall once you're genuinely eating less, and fat tissue takes time to mobilise. Fluid shifts early in treatment can also mask early fat loss on a standard bathroom scale.
The practical upshot: in the first week or two, look for reduced appetite, a feeling of fullness after smaller portions, and less interest in snacking between meals. Those are the signs the medicine is doing its job. The scales tend to follow, not lead. If you're curious how long Mounjaro takes to start working and what to expect as it does, the detail is in our guide on how long Mounjaro takes to start working.
The SURMOUNT-1 trial (a large phase 3 study whose results were published in the New England Journal of Medicine and which informed NICE's appraisal of tirzepatide) tracked adults with obesity over 72 weeks. At the 15mg maintenance dose, participants lost an average of around 20–21% of body weight by the end of the study. That headline figure is well known. Less discussed is the shape of the curve getting there.
Early weight loss in the trial was gradual. The steep part of the curve came as doses increased and participants settled into their maintenance level, typically from around weeks 12–20 onwards. This matters for setting realistic expectations: the first four to eight weeks are biologically productive even when the results look modest, because the body is adapting to a new dose, appetite patterns are shifting, and the foundation for larger losses later is being laid.
For a more granular breakdown of how weight loss progresses over a longer period, the timeframe for losing 10kg on Mounjaro puts specific milestones in context. The NHS medicines page for tirzepatide also summarises what to expect and when to contact a clinician if something feels wrong.
Mounjaro is licensed in the UK in six strengths: 2.5, 5, 7.5, 10, 12.5 and 15mg. Treatment always begins at 2.5mg. That starting pen is sitting in a lot of fridges right now with people wondering why it isn't doing more, and the answer is that 2.5mg exists to let your body adjust to the medicine, not to deliver the full therapeutic effect. Think of it as calibration, not treatment.
Dose increases happen roughly every four weeks, guided by a prescriber. Each step up tends to produce a fresh increment of appetite reduction, which is why weight loss often accelerates in phases rather than flowing in a straight line. If side effects (typically nausea or digestive discomfort) are more pronounced after a step up, that usually settles within a week or two as the body acclimates.
Titration timing and decisions about dose changes are always made by your prescriber, not by the medicine itself. The full Mounjaro overview covers the licensed dose range and how the titration process works in detail. For a close look at what affects the pace of response in the first weeks, the timeline from first injection to first effect is worth reading alongside this page.
Individual response varies, and a few practical things shape it. Starting weight and metabolic profile both play a role, someone with a higher BMI may notice appetite changes at a lower dose than someone closer to the treatment threshold. Diet quality matters too: because the medicine reduces overall appetite rather than blocking specific foods, the composition of what you eat while appetite is suppressed affects how much actual weight shifts.
Physical activity doesn't accelerate the medicine's mechanism directly, but it influences how the weight lost breaks down between fat and lean tissue, which matters for health outcomes and for maintaining the loss. The weight-loss treatment overview has more on lifestyle factors that work alongside any prescription medicine.
It's also worth knowing that individual responses in trials showed real spread: some participants lost weight faster than the average, some more slowly, and both were within normal variation. A slower start in the first month is not a sign the medicine isn't working. Persistent lack of any appetite change after several weeks is a conversation to have with your prescriber, not a reason to self-adjust your dose. Cost is a separate consideration for many people; the context around Mounjaro's UK pricing is useful background if you're weighing up your options.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.